Implementing family health history risk stratification in primary care: Impact of guideline criteria on populations and resource demand

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 166, Issue 1, 2014, Pages 24-33

  Orlando, Lori A ^a   Wu, R Ryanne ^a   Beadles, Chris ^d   Himmel, Tiffany ^b   Buchanan, Adam H ^d   Powell, Karen P ^c   Hauser, Elizabeth R ^b,d   Henrich, Vincent C ^e   Ginsburg, Geoffrey S ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c Duke Institute for Genome Sciences and Policy ^*  (United States)

^d Cone Health System ^*

^e UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Family history; Health services; Primary prevention; Risk stratification

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CLINICAL DECISION MAKING; COLON CANCER; DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE; FAMILIAL CANCER; FAMILY HEALTH HISTORY RISK; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; GENETIC DISORDER; GENOMICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVARY CANCER; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT; RISK MANAGEMENT; THROMBOSIS;

FAMILY HISTORY; HEALTH SERVICES; PRIMARY PREVENTION; RISK STRATIFICATION;

ADULT; DECISION SUPPORT TECHNIQUES; GENETIC COUNSELING; GENETICS, MEDICAL; HUMANS; INDIVIDUALIZED MEDICINE; MEDICAL HISTORY TAKING; NEOPLASMS; NORTH CAROLINA; PRIMARY HEALTH CARE; RISK ASSESSMENT; THROMBOSIS;

EID: 84896314602     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.31388     Document Type: Article

References (36)

1. Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. 2000. Family history-taking in community family practice: Implications for genetic screening. Genet Med 2:180-185.
2. Akaike H. 1974. A new look at the statistical model identification. IEEE Trans Automatic Control 19:716-723.
3. Berg AO BM, Botkin JR, Driscoll DA, Fishman PA, Guarino PD, Hiatt RA, Jarvik GP, Millon-Underwood S, Morgan TM, Mulvihill JJ, Pollin TI, Schimmel SR, Stefanek ME, Vollmer WM, Williams JK. 2009; National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health. Annals of Internal Medicine 151:872-877.
4. Berliner JL, Fay AM, Practice Issues Subcommittee of the National Society of Genetic Counselors' Familial Cancer Risk Counseling Special Interest G. 2007. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: Recommendations of the National Society of Genetic Counselors. J Genet Counsel 16:241-260.
5. Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G., 2002. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701-2712.
6. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. 2004. Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:401S-428S.
7. Cohn WF, Ropka ME, Pelletier SL, Barrett JR, Kinzie MB, Harrison MB, Liu Z, Miesfeldt S, Tucker AL, Worrall BB, Gibson J, Mullins IM, Elward KS, Franko J, Guterbock TM, Knaus WA. 2010. Health heritage, a web-based tool for the collection and assessment of family health history: Initial user experience and analytic validity. Public Health Genomics 13:477-491.
8. Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. 2012. Effectiveness-implementation hybrid designs: Combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care 50:217-226.
9. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. 1998. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388.
10. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. 1989. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886.
11. Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491:56-65.
12. Gramling R, Nash J, Siren K, Eaton C, Culpepper L. 2004. Family physician self-efficacy with screening for inherited cancer risk. Ann Fam Med 2:130-132.
13. Grimes DA, Stuart GS, Levi EE. 2012. Screening women for oral contraception: Can family history identify inherited thrombophilias? Obstet Gynecol 120:889-895.
14. Hampel H, Sweet K, Westman JA, Offit K, Eng C. 2004. Referral for cancer genetics consultation: A review and compilation of risk assessment criteria. J Med Genet 41:81-91.
15. Hemminki K, Li X, Sundquist K, Sundquist J. 2008. Familial risks for common diseases: Etiologic clues and guidance to gene identification. Mutat Res 658:247-258.
16. Hendriks YM, de Jong AE, Morreau H, Tops CM, Vasen HF, Wijnen JT, Breuning MH, Brocker-Vriends AH. 2006. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): A guide for clinicians. CA Cancer J Clin 56:213-225.
17. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, Thorson A, Winawer SJ, American Cancer Society Colorectal Cancer Advisory G, Force USM-ST. American College of Radiology Colon Cancer C. 2008. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58:130-160.
18. National Comprehensive Cancer Network. 2011. Family history risk markers for hereditary cancer syndrome.
19. Neale RE, Stiller CA, Bunch KJ, Milne E, Mineau GP, Murphy MF. 2013. Familial aggregation of childhood and adult cancer in the Utah genealogy. Int J Cancer 133:2953-2960.
20. O'Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT, Family Healthware Impact Trial g. 2009. Familial risk for common diseases in primary care: The Family Healthware Impact Trial. Am J Prev Med 36:506-514.
21. Orlando LA, Hauser ER, Christianson C, Powell KP, Buchanan AH, Chesnut B, Agbaje AB, Henrich VC, Ginsburg G. 2011. Protocol for implementation of family health history collection and decision support into primary care using a computerized family health history system. BMC Health Serv Res 11:264.
22. Orlando LA, Buchanan AH, Hahn SE, Christianson CA, Powell KP, Skinner CS, Chesnut B, Blach C, Due B, Ginsburg GS, Henrich VC. 2013a. Development and validation of a Primary Care-based family health history and decision support program (MeTree©). N C Med J 74:287-296.
23. Orlando LA, Henrich V, Hauser ER, Wilson C, Ginsburg GS. 2013b. The genomic medicine model: An integrated approach to implementation of family health history in primary care. Personalized Med 10:295-306.
24. Ozanne EM, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, Jellinek M, Cronin C, Milham F, Dowd D, Block C, Lockhart D, Sharko J, Grinstein G, Hughes KS. 2009. Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J 15:155-162.
25. R Core Team. 2013. R: A Language and Environment for Statistical Computing. Foundation for Statistical Computing.
26. Risch N. 1990. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229-241.
27. Rubinstein WS, Acheson LS, O'Neill SM, Ruffin MT, Wang C, Beaumont JL, Rothrock N, Family Healthware Impact Trial G. 2011. Clinical utility of family history for cancer screening and referral in primary care: A report from the Family Healthware Impact Trial. Genet Med 13:956-965.
28. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS, Russell CA, American Cancer Society Breast Cancer Advisory G. 2007. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89.
29. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD, Team PP. 2012. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366:2345-2357.
30. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S. 2004. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268.
31. U.S., Preventive Services Task Force. 2005. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Ann Intern Med 143:355-361.
32. Vasen HF, Watson P, Mecklin JP, Lynch HT. 1999. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116:1453-1456.
33. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL III, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N, National Surgical Adjuvant B, Bowel P. 2006. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295:2727-2741.
34. Watson EK, Shickle D, Qureshi N, Emery J, Austoker J. 1999. The 'new genetics' and primary care: GPs' views on their role and their educational needs. Fam Pract 16:420-425.
35. Wu RR, Orlando LA, Himmel TL, Buchanan AH, Powell KP, Hauser ER, Agbaje AB, Henrich VC, Ginsburg GS. 2013. Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: A type 2 hybrid controlled implementation-effectiveness trial. BMC Fam Pract 14:111.
36. Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ. 2009. Developing Family Healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis 6:A33.